|6th February 2019
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry.
Read on for expert consultant Will Frostick’s analysis of the current and future treatment landscape. Discover how healthcare professionals make treatment decisions and their common misconceptions about the disease from Dr Tim Vollmer, one of America’s leading MS Specialist Neurologists. Learn about the patient journey from multi-awardwinning patient advocate Trishna Bharadia.
Don’t forget to check out our customer journey maps, which chart the patient and healthcare professional’s experience, from first symptoms to initial diagnosis and treatment. Blue Latitude Health is experienced in helping clients to develop products and services that save and transform lives, and the MS therapy area is no exception.
|16th August 2019
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to make a more accurate treatment decision. Here we discuss the barriers, opportunities and potential outcomes of the precision medicine era in healthcare.
|26th July 2019
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist and Director of Public Health at Genomics England, to find out how the NHS is achieving this goal.
|16th July 2019
The number of mental health research programmes in larger drug firms has shrunk by 70% in the past decade. Blue Latitude Health Senior Associate Consultant Sana Rahim explores this drop in investment and explains why developing a market-orientated model is vital for making progress.